Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Teeling

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Neurology|May 3, 2015
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trialJoseph Butchart, Laura Brook, Vivienne Hopkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosisLone Skov, Frank J Beurskens, Claus O C Zachariae, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Journal of Neurochemistry|June 2, 2016
Targeting innate immunity for neurodegenerative disorders of the central nervous systemKatrin I Andreasson, Adam D Bachstetter, Marco Colonna, et al.
Scientific Reports|May 29, 2019
Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathwayElizabeth K Benedikz, Dalan Bailey, Charlotte N L Cook, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Neurology|May 3, 2015
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trialJoseph Butchart, Laura Brook, Vivienne Hopkins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2008
IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosisLone Skov, Frank J Beurskens, Claus O C Zachariae, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2013
Developing novel blood-based biomarkers for Alzheimer's diseaseHeather M Snyder, Maria C Carrillo, Francine Grodstein, et al.
Journal of Neurochemistry|June 2, 2016
Targeting innate immunity for neurodegenerative disorders of the central nervous systemKatrin I Andreasson, Adam D Bachstetter, Marco Colonna, et al.
Scientific Reports|May 29, 2019
Bacterial flagellin promotes viral entry via an NF-kB and Toll Like Receptor 5 dependent pathwayElizabeth K Benedikz, Dalan Bailey, Charlotte N L Cook, et al.
Pageof 2